Conference Coverage EHA 2023 – Focus on Multiple Myeloma (US)
The latest therapeutic developments in multiple myeloma – how will they change our approach to treatment patterns?
Faculty Members
Ajai Chari, MD
Mount Sinai, New York, NY, USA
Krina K. Patel, MD
MD Anderson Cancer Center, Houston, TX, USA
Noopur Raje, MD
Massachusetts General Hospital, Boston, MA, USA
Luciano J. Costa, MD, PhD
University of Alabama at Birmingham, Birmingham, AL, USA
Amrita Krishnan, MD
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
REPORT TOPICS
- Treatment in Transplant-Eligible and Smoldering Multiple Myeloma
- NDMM: Transplant-Ineligible Multiple Myeloma
- Relapsed/Refractory Multiple Myeloma: Small Molecules
- Relapsed/Refractory Multiple Myeloma: Antibodies and Bispecifics
- Relapsed/Refractory Multiple Myeloma: CAR T
